Biomarkers in DNA Samples From Younger Patients With Newly Diagnosed Acute Myeloid Leukemia Receiving Gemtuzumab Ozogamicin
Clinical trial NCT01139320 · COMPLETED
Trial details
- NCT number
- NCT01139320
- Sponsor
- Children's Oncology Group
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2009-09-01
- Primary completion
- 2016-05-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.